Hologic to Webcast Presentations at Upcoming Investor Conferences

MARLBOROUGH, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/holx?src=hash” target=”_blank”gt;#holxlt;/agt;–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will
present at these upcoming investor conferences:

  • The Bank of America Merrill Lynch Healthcare Conference 2019 in Las
    Vegas, NV on Tuesday, May 14 at 1 p.m. Pacific Time.
  • The UBS Global Healthcare Conference in New York, NY on Monday, May 20
    at 8 a.m. Eastern Time (ET).
  • The 2019 RBC Capital Markets Global Healthcare Conference in New York,
    NY on Tuesday, May 21 at 8:30 a.m. ET.

Each presentation will be webcast live and may be accessed through a
link on the investors section of Hologic’s website at http://investors.hologic.com.
The webcasts will be available for 30 days following the events.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily
focused on improving women’s health and well-being through early
detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro
Senior Investor Relations Specialist
(858)
410-8904
paula.izidoro@hologic.com

Staff

Recent Posts

Genflow Biosciences PLC Announces Publication of a Key European Patent

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

2 hours ago

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…

11 hours ago

Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…

11 hours ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…

11 hours ago

Music’s Healing Influence on Our Physiology

Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…

14 hours ago

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…

14 hours ago